These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

414 related items for PubMed ID: 20424123

  • 1. Transcriptional repression of SKP2 is impaired in MYCN-amplified neuroblastoma.
    Muth D, Ghazaryan S, Eckerle I, Beckett E, Pöhler C, Batzler J, Beisel C, Gogolin S, Fischer M, Henrich KO, Ehemann V, Gillespie P, Schwab M, Westermann F.
    Cancer Res; 2010 May 01; 70(9):3791-802. PubMed ID: 20424123
    [Abstract] [Full Text] [Related]

  • 2. SKP2 is a direct transcriptional target of MYCN and a potential therapeutic target in neuroblastoma.
    Evans L, Chen L, Milazzo G, Gherardi S, Perini G, Willmore E, Newell DR, Tweddle DA.
    Cancer Lett; 2015 Jul 10; 363(1):37-45. PubMed ID: 25843293
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Suppression of centrosome amplification after DNA damage depends on p27 accumulation.
    Sugihara E, Kanai M, Saito S, Nitta T, Toyoshima H, Nakayama K, Nakayama KI, Fukasawa K, Schwab M, Saya H, Miwa M.
    Cancer Res; 2006 Apr 15; 66(8):4020-9. PubMed ID: 16618721
    [Abstract] [Full Text] [Related]

  • 7. MYCN-directed centrosome amplification requires MDM2-mediated suppression of p53 activity in neuroblastoma cells.
    Slack AD, Chen Z, Ludwig AD, Hicks J, Shohet JM.
    Cancer Res; 2007 Mar 15; 67(6):2448-55. PubMed ID: 17363562
    [Abstract] [Full Text] [Related]

  • 8. Use of RNA interference to elucidate the effect of MYCN on cell cycle in neuroblastoma.
    Woo CW, Tan F, Cassano H, Lee J, Lee KC, Thiele CJ.
    Pediatr Blood Cancer; 2008 Feb 15; 50(2):208-12. PubMed ID: 17420990
    [Abstract] [Full Text] [Related]

  • 9. ID2 expression is not associated with MYCN amplification or expression in human neuroblastomas.
    Wang Q, Hii G, Shusterman S, Mosse Y, Winter CL, Guo C, Zhao H, Rappaport E, Hogarty MD, Maris JM.
    Cancer Res; 2003 Apr 01; 63(7):1631-5. PubMed ID: 12670915
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. High level MycN expression in non-MYCN amplified neuroblastoma is induced by the combination treatment nutlin-3 and doxorubicin and enhances chemosensitivity.
    Peirce SK, Findley HW.
    Oncol Rep; 2009 Dec 01; 22(6):1443-9. PubMed ID: 19885598
    [Abstract] [Full Text] [Related]

  • 14. Expression of NLRR3 orphan receptor gene is negatively regulated by MYCN and Miz-1, and its downregulation is associated with unfavorable outcome in neuroblastoma.
    Akter J, Takatori A, Hossain MS, Ozaki T, Nakazawa A, Ohira M, Suenaga Y, Nakagawara A.
    Clin Cancer Res; 2011 Nov 01; 17(21):6681-92. PubMed ID: 21908575
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Key role for p27Kip1, retinoblastoma protein Rb, and MYCN in polyamine inhibitor-induced G1 cell cycle arrest in MYCN-amplified human neuroblastoma cells.
    Wallick CJ, Gamper I, Thorne M, Feith DJ, Takasaki KY, Wilson SM, Seki JA, Pegg AE, Byus CV, Bachmann AS.
    Oncogene; 2005 Aug 25; 24(36):5606-18. PubMed ID: 16007177
    [Abstract] [Full Text] [Related]

  • 18. E2F proteins regulate MYCN expression in neuroblastomas.
    Strieder V, Lutz W.
    J Biol Chem; 2003 Jan 31; 278(5):2983-9. PubMed ID: 12438307
    [Abstract] [Full Text] [Related]

  • 19. A SP1/MIZ1/MYCN repression complex recruits HDAC1 at the TRKA and p75NTR promoters and affects neuroblastoma malignancy by inhibiting the cell response to NGF.
    Iraci N, Diolaiti D, Papa A, Porro A, Valli E, Gherardi S, Herold S, Eilers M, Bernardoni R, Della Valle G, Perini G.
    Cancer Res; 2011 Jan 15; 71(2):404-12. PubMed ID: 21123453
    [Abstract] [Full Text] [Related]

  • 20. Anaplastic Lymphoma Kinase (ALK) regulates initiation of transcription of MYCN in neuroblastoma cells.
    Schönherr C, Ruuth K, Kamaraj S, Wang CL, Yang HL, Combaret V, Djos A, Martinsson T, Christensen JG, Palmer RH, Hallberg B.
    Oncogene; 2012 Dec 13; 31(50):5193-200. PubMed ID: 22286764
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.